John Manusu
Directeur Général chez PrIME Biologics Pte Ltd.
Profil
John Manusu is currently the Managing Director and Director at PrIME Biologics Pte Ltd.
He previously worked as the Non-Executive Chairman at Memphasys Ltd.
from 2012 to 2013 and as a Director and Director-Investor Relations at Arturus Capital Ltd.
from 1987 to 2007.
Postes actifs de John Manusu
| Sociétés | Poste | Début |
|---|---|---|
PrIME Biologics Pte Ltd.
 PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore. | Directeur Général | 01/01/1985 |
Anciens postes connus de John Manusu
| Sociétés | Poste | Fin |
|---|---|---|
| MEMPHASYS | Président | 29/11/2013 |
Arturus Capital Ltd.
 Arturus Capital Ltd. Financial ConglomeratesFinance Arturus Capital Ltd. is an investment company that holds interests in mining and gas projects. The company was founded on May 31, 1972 and is headquartered in North Perth, Australia. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEMPHASYS | Health Technology |
| Entreprise privées | 2 |
|---|---|
Arturus Capital Ltd.
Arturus Capital Ltd. Financial ConglomeratesFinance Arturus Capital Ltd. is an investment company that holds interests in mining and gas projects. The company was founded on May 31, 1972 and is headquartered in North Perth, Australia. | Finance |
PrIME Biologics Pte Ltd.
PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore. | Health Technology |
